人参炔醇在治疗癌症方面的研究进展
Research Progress of Panaxynol in the Treatment of Cancer
DOI: 10.12677/ACM.2023.1392022, PDF,    科研立项经费支持
作者: 朱元虎, 陈俊杰：济宁医学院第二临床医学院，山东 济宁；姚安彤, 高 洋：济宁医学院中西医结合学院，山东 济宁；李 玉：潍坊医学院护理学院，山东 潍坊；来路皓*：济宁医学院协同创新中心，山东 济宁
关键词: 人参炔醇；胰腺癌；肺癌；乳腺癌；Panaxynol； Pancreatic Cancer； Lung Cancer； Breast Cancer
摘要: 已有研究表明，人参炔醇有诸多药理作用，如抗癌、降压、抗炎、抗抑郁、神经细胞保护、预防动脉粥样硬化等作用，且在抗癌方面发挥着极其重要的作用。本文旨在阐述人参炔醇在胰腺癌、肺癌及乳腺癌中的作用机制和研究进展。
Abstract: Studies have shown that panaxynol has many pharmacological effects, such as anti-cancer, antihy-pertensive, anti-inflammatory, anti-depression, nerve cell protection, prevention of atherosclerosis and other effects, and plays an extremely important role in anti-cancer. This article aims to review the mechanism and research progress of panaxynol in pancreatic cancer, lung cancer and breast cancer.
文章引用：朱元虎, 陈俊杰, 姚安彤, 李玉, 高洋, 来路皓. 人参炔醇在治疗癌症方面的研究进展[J]. 临床医学进展, 2023, 13(9): 14445-14450. https://doi.org/10.12677/ACM.2023.1392022

参考文献

[1] Kobaek-Larsen, M., El-Houri, R.B., Christensen, L.P., et al. (2017) Dietary Polyacetylenes, Falcarinol and Falcarindiol, Isolated from Carrots Prevents the Formation of Neoplastic Lesions in the Colon of Azoxymethane-Induced Rats. Food & Function, 8, 964-974. [Google Scholar] [CrossRef] 
[2] Heydenreuter, W., Kunold, E. and Sieber, S.A. (2015) Alkynol Natural Products Target ALDH2 in Cancer Cells by Irreversible Binding to the Active Site. Chemical Communications (Camb), 51, 15784-15787. [Google Scholar] [CrossRef] 
[3] Tan, K.W., Killeen, D.P., Li, Y., et al. (2014) Dietary Polyacetylenes of the Falcarinol Type Are Inhibitors of Breast Cancer Resistance Protein (BCRP/ABCG2). European Journal of Pharmacology, 723, 346-352. [Google Scholar] [CrossRef] [PubMed]
[4] Cheung, S.S.C., Hasman, D., Khelifi, D., et al. (2019) Devil’s Club Falcarinol-Type Polyacetylenes Inhibit Pancreatic Cancer Cell Proliferation. Nutrition and Cancer, 71, 301-311. [Google Scholar] [CrossRef] [PubMed]
[5] Yang, Z.H., Sun, K., Yan, Z.H., et al. (2010) Panaxynol Protects Cortical Neurons from Ischemia-Like Injury by Up-Regulation of HIF-1α Expression and Inhibition of Apoptotic Cascade. Chemico-Biological Interactions, 183, 165-171. [Google Scholar] [CrossRef] [PubMed]
[6] 段贤春, 汪永忠, 居靖, 等. 人参炔醇研究进展[J]. 安徽医药, 2008, 12(1): 1-3.
[7] 王泽剑, 吴英理, 林琦, 等. 人参炔醇对HL-60细胞体外诱导分化作用的研究[J]. 中草药, 2003, 34(8): 67-69.
[8] Park, H.J., Rhee, M.H., Park, K.M., et al. (1995) Effect of Monsapomn Fractionfrom Panax ginseng on cGMP and Thromboxane A2 in Human Plate-Let Aggregation. Journal of Ethnopharmacology, 49, 157-162. [Google Scholar] [CrossRef] [PubMed]
[9] Tanaka, S. (1977) The Analgesic Effect of Panaxynol. Phytochemistry, 27, 486-489. [Google Scholar] [CrossRef] 
[10] Wang, Z.J., Nie, B.M., Chen, H.Z., et al. (2006) Panaxynol Induces Neurite Outgrowth in PC12D Cells via cAMP- and MAP Kinase-Dependent Mechanisms. Chemico-Biological Interactions, 159, 58-64. [Google Scholar] [CrossRef] [PubMed]
[11] Miller, K.D., et al. (2021) Cancer statistics, 2021. CA: A Cancer Journal for Clinicians, 71, 7-33. [Google Scholar] [CrossRef] [PubMed]
[12] Cabasag, C.J., Ferlay, J., et al. (2021) Pancreatic Cancer: An Increasing Global Public Health Concern. Gut, 71, 1686-1687. [Google Scholar] [CrossRef] [PubMed]
[13] Sun, D., Cao, M., Li, H., et al. (2020) Cancer Burden and Trends in China: A Review and Comparison with Japan and South Korea. Chinese Journal of Cancer Research, 32, 129-139. [Google Scholar] [CrossRef] [PubMed]
[14] 王颖. 人参炔醇体外抑制人胰腺癌SW1990细胞迁移作用研究[J]. 中华肿瘤防治杂志, 2015, 22(21): 1662-1666. [Google Scholar] [CrossRef] 
[15] Hermann, P.C., Huber, S.L., Herrler, T., et al. (2007) Dis-tinct Populations of Cancer Stem Cells Determine Tumor Growth and Metastatic Activity in Human Pancreatic Cancer. Cell Stem Cell, 1, 313-323. [Google Scholar] [CrossRef] [PubMed]
[16] Tzanakis, N.E., Peros, G., Karakitsos, P., et al. (2009) Prognostic Significance of p53 and Ki67 Proteins Expression in Greek Gastric Cancer Patients. Acta Chirurgica Belgica, 109, 606-611. [Google Scholar] [CrossRef] [PubMed]
[17] Czyzewska, J., Guzińska-Ustymowicz, K., Lebelt, A., et al. (2004) Evaluation of Proliferating Markers Ki-67, PCNA in Gastric Cancers. Roczniki Akademii Medycznej w Bialym-stoku, 49, 64-66.
[18] 黄文斯. 人参炔醇抑制胰腺癌干细胞的增殖及自我更新[D]: [硕士学位论文]. 镇江: 江苏大学, 2016.
[19] 王颖. 人参炔醇对胰腺癌干细胞分化及侵袭转移作用的基础研究[D]: [硕士学位论文]. 镇江: 江苏大学, 2017.
[20] 张思楠, 张丽娜. 吉西他滨在胰腺癌治疗中的研究进展[J]. 广东化工, 2022, 49(16): 86-87, 92.
[21] Dongre, A. and Weinberg, R.A. (2018) New Insights into the Mechanisms of Epithelial-Mesenchymal Transition and Implications for Cancer. Nature Reviews Molecular Cell Biology, 20, 69-84. [Google Scholar] [CrossRef] [PubMed]
[22] Buchsbaum, D.J., Bonner, J.A., Grizzle, W.E., et al. (2002) Treatment of Pancreatic Cancer Xenografts with Erbitux (IMC-C225) Anti-EGFR Antibody, Gemcitabine, and Radiation. International Journal of Radiation Oncology, Biology, Physics, 54, 1180-1193. [Google Scholar] [CrossRef] 
[23] Arends, J.J., Sleeboom, H.P., Leys, M.B., et al. (2005) A Phase II Study of Raltitrexed and Gemcitabine in Patients with Advanced Pancreatic Carcinoma. British Journal of Can-cer, 92, 445-448. [Google Scholar] [CrossRef] [PubMed]
[24] Abrams, R.A. (2003) Adjuvant Therapy for Pancre-atic Adenocarcinoma: What Have We Learned since 1985? International Journal of Radiation Oncology, Biology, Phys-ics, 56, 3-9. [Google Scholar] [CrossRef] 
[25] Reya, T., Morrison, S.J., Clarke, M.F., et al. (2001) Stem Cells, Cancer and Cancer Stem Cells. Nature, 414, 105-111. [Google Scholar] [CrossRef] [PubMed]
[26] 杨佩儒. 人参炔醇联合吉西他滨对胰腺癌干细胞分化及活性的影响[J]. 江苏大学学报(医学版), 2019, 29(3): 221-225. [Google Scholar] [CrossRef] 
[27] Centers for Disease Control and Prevention (2018) Basic Information about Lung Cancer.
https://www.cdc.gov/cancer/lung/basic_info
[28] American Lung Association (2018) Lung Cancer Fact Sheet.
https://www.cancer.org/content/dam/cancer-org/cancer-control/en/booklets-flyers/lung-cancer-fact-sheet.pdf
[29] Torre, L.A., Bray, F., Siegel, R.L., Ferlay, J., Lortet-Tieulent, J. and Jemal, A. (2015) Global Cancer Statistics, 2012. CA: A Cancer Journal for Clinicians, 65, 87-108. [Google Scholar] [CrossRef] [PubMed]
[30] Jung, K.W., Won, Y.J., Oh, C.M., Kong, H.J., Lee, D.H. and Lee, K.H. (2017) Prediction of Cancer Incidence and Mortality in Korea, 2017. Cancer Research and Treatment, 49, 306-312. [Google Scholar] [CrossRef] [PubMed]
[31] Mercer, R. (2020) Canadian Can-cer Statistics: A 2020 Special Report on Lung Cancer. Canadian Centre for Applied Research in Cancer Control, Van-couver.
[32] Carper, S.W., Duffy, J.J. and Gerner, E.W. (1987) Heat Shock Proteins in Thermo Tolerance and Other Cellular Physiological Processes. Cancer Research, 47, 5249-5255.
[33] Jego, G., Hazoume, A., Seigneuric, R. and Garrido, C. (2013) Targeting Heat Shock Proteins in Cancer. Cancer Letters, 332, 275-285. [Google Scholar] [CrossRef] [PubMed]
[34] Taipale, M., Jarosz, D.F. and Lindquist, S. (2010) HSP90 at the Hub of Protein Homeostasis: Emerging Mechanistic Insights. Nature Reviews Molecular Cell Biology, 11, 515-528. [Google Scholar] [CrossRef] [PubMed]
[35] Neckers, L. and Workman, P. (2012) Hsp90 Molecular Chaperone Inhibitors: Are We There Yet? Clinical Cancer Research, 18, 64-76. [Google Scholar] [CrossRef] 
[36] Isaacs, J.S., Xu, W. and Neckers, L. (2003) Heat Shock Protein 90 as a Molecular Target for Cancer Therapeutics. Cancer Cell, 3, 213-217. [Google Scholar] [CrossRef] 
[37] Modi, S., Stopeck, A., Linden, H., et al. (2011) HSP90 Inhi-bition Is Effective in Breast Cancer: A Phase II Trial of T Anespimycin (17-AAG) plus Trastuzumab in Patients with HER2-Positive Metastatic Breast Cancer Progressing on Trastuzumab. Clinical Cancer Research, 17, 5132-5139. [Google Scholar] [CrossRef] 
[38] Le, T.H., Nguyen, T.H., Min, H., et al. (2018) Panaxynol, a Natural Hsp90 Inhibitor, Effectively Targets both Lung Cancer Stem and Non-Stem Cells. Cancer Letters, 412, 297-307. [Google Scholar] [CrossRef] [PubMed]
[39] Torre, L.A., Bray, F., Siegel, R.L., et al. (2015) Global Cancer Statistics, 2012. CA: A Cancer Journal for Clinicians, 65, 87-108. [Google Scholar] [CrossRef] [PubMed]
[40] 林波, 李惠萍, 杨娅娟, 等. 高校女生乳腺癌知识-信念-行为问卷的编制与评价[J]. 安徽医学, 2013, 34(2): 203-206.
[41] Huang, Z., Wen, W., Zheng, Y., et al. (2016) Breast Cancer Incidence and Mortality: Trends over 40 Years among Women in Shanghai, China. Annals of Oncology, 27, 1129-1134. [Google Scholar] [CrossRef] [PubMed]
[42] 曹毛毛, 陈万青. GLOBOCAN 2020全球癌症统计数据解读[J]. 中国医学前沿杂志(电子版), 2021, 13(3): 63-69.
[43] 张柏林, 张倩, Priya G. Sivasubramaniam, 等. 中国年轻乳腺癌发病危险因素——多中心十年回顾性研究[J]. 中国肿瘤, 2015, 24(12): 1042-1047.
[44] 杜建姝. 中国乳腺癌现状[J]. 世界最新医学信息文摘, 2019, 19(46): 371-372.
[45] Anders, C.K., Hsu, D.S., Broadwater, G., et al. (2008) Young Age at Diagnosis Correlates with Worse Prognosis and Defines a Subset of Breast Cancers with Shared Patterns of Gene Expression. Journal of Clinical Oncology, 26, 3324-3330. [Google Scholar] [CrossRef] 
[46] Jemal, A., Siegel, R., Ward, E., et al. (2007) Cancer Statistics, 2007. CA: A Cancer Journal for Clinicians, 57, 43-66. [Google Scholar] [CrossRef] [PubMed]
[47] Anastasiadi, Z., Lianos, G.D., Ignatiadou, E., et al. (2017) Breast Cancer in Young Women: An Overview. Updates in Surgery, 69, 313-317. [Google Scholar] [CrossRef] [PubMed]
[48] 师金, 梁迪, 李道娟, 等. 全球女性乳腺癌流行情况研究[J]. 中国肿瘤, 2017, 26(9): 683-690.
[49] 章颖, 柳光宇. 年轻女性早期乳腺癌诊治进展[J]. 天津医药, 2016, 44(4): 408-412.
[50] 林波, 王玲, 李惠萍, 等. 高校女生乳腺癌知信行及其影响因素的调查分析[J]. 护理学杂志, 2015, 30(7): 85-87.
[51] 殷文瑾, 陆劲松, 柳光宇, 等. 年轻乳腺癌(≤35岁)患者死亡风险规律的分析[J]. 中国癌症杂志, 2007(2): 118-120.
[52] 罗悦琼, 廖大忠. 参白扶正颗粒联合阿帕替尼治疗多线治疗失败的转移性乳腺癌的疗效研究[J]. 中国全科医学, 2018, 21(25): 3107-3112.
[53] Liu, N., Li, P., Wang, J., et al. (2020) Factors Influencing Breast Cancer Awareness: A Cross-Sectional Study in China. Journal of Comparative Effectiveness Research, 9, 679-689. [Google Scholar] [CrossRef] [PubMed]
[54] 邵琦. 人参炔醇重塑巨噬细胞表型和功能抑制乳腺癌发生发展的机制研究[D]: [硕士学位论文]. 镇江: 江苏大学, 2020.

为你推荐